294 related articles for article (PubMed ID: 18779050)
1. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.
Barnes D; Kunitomi M; Vignuzzi M; Saksela K; Andino R
Cell Host Microbe; 2008 Sep; 4(3):239-48. PubMed ID: 18779050
[TBL] [Abstract][Full Text] [Related]
2. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
4. Engineering attenuated virus vaccines by controlling replication fidelity.
Vignuzzi M; Wendt E; Andino R
Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
[TBL] [Abstract][Full Text] [Related]
6. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
7. Random selection: a model for poliovirus infection of the central nervous system.
Georgescu MM; Balanant J; Ozden S; Crainic R
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus tropism and attenuation are determined after internal ribosome entry.
Kauder SE; Racaniello VR
J Clin Invest; 2004 Jun; 113(12):1743-53. PubMed ID: 15199409
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus biology.
Minor PD
Structure; 1996 Jul; 4(7):775-8. PubMed ID: 8805561
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-555 has potent antiviral properties against poliovirus.
Shim BS; Wu W; Kyriakis CS; Bakre A; Jorquera PA; Perwitasari O; Tripp RA
J Gen Virol; 2016 Mar; 97(3):659-668. PubMed ID: 26683768
[TBL] [Abstract][Full Text] [Related]
11. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
Ren RB; Moss EG; Racaniello VR
J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
[TBL] [Abstract][Full Text] [Related]
12. A Transgenic Mouse Model of Poliomyelitis.
Koike S; Nagata N
Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
[TBL] [Abstract][Full Text] [Related]
13. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
Georgescu MM; Delpeyroux F; Crainic R
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2343-8. PubMed ID: 7561775
[TBL] [Abstract][Full Text] [Related]
14. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
15. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains.
MartÃn J; Crossland G; Wood DJ; Minor PD
J Gen Virol; 2003 Jul; 84(Pt 7):1781-1788. PubMed ID: 12810872
[TBL] [Abstract][Full Text] [Related]
16. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology and the control of viral vaccines.
Minor PD; Macadam A; Cammack N; Dunn G; Almond JW
FEMS Microbiol Immunol; 1990 Nov; 2(4):207-13. PubMed ID: 2178354
[TBL] [Abstract][Full Text] [Related]
20. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
